Use of sulfated oligosaccharides in the manufacture of a medicament for the treatment of hepatocellular carcinoma patients after surgical resection

摘要

Reducing intrahepatic tumor recurrence and disease-free in HCC patients with microvascular involvement after curative liver resection, excluding patients with hepatocellular carcinoma (HCC) without vascular involvement and HCC patients with macrovascular involvement The use of sulfated oligosaccharides is provided in the manufacture of a medicament for increasing the survival time.